Drug intelligence / Profile preview

GrB-Fc-SD1

Development stage
Preclinical
Lead developer
AbBC Therapies
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

GrB-Fc-SD1 is a preclinical-stage recombinant fusion protein therapeutic being developed by AbBC Therapies for the treatment of pancreatic and ovarian cancers. The drug is composed of a human single-domain antibody (SD1) that specifically targets Region III of the mesothelin glycoprotein, fused to a Granzyme B-Fc construct. This fusion protein is designed to deliver the cytotoxic serine protease Granzyme B directly into mesothelin-overexpressing tumor cells. Upon internalization, Granzyme B triggers apoptosis via both caspase-dependent and caspase-independent pathways. Preclinical studies have demonstrated nanomolar-range cytotoxicity and significant in vivo efficacy in tumor xenograft models.

Other names
Granzyme B-Fc-SD1SD1-GrB-FcSD-1-GrB-FcSD 1-GrB-Fc
02

Targets

Mesothelin

Beyond the preview

Go deeper on GrB-Fc-SD1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GrB-Fc-SD1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call